Literature DB >> 17607788

Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients.

Bui Xuan Truong1, Yoshihiko Yano, Yasushi Seo, Tran Minh Phuong, Yasuhito Tanaka, Hirotaka Kato, Akira Miki, Takako Utsumi, Takeshi Azuma, Nguyen Khanh Trach, Masashi Mizokami, Yoshitake Hayashi, Masato Kasuga.   

Abstract

Hepatitis B virus (HBV) subgenotypes Cs (C1) and Ce (C2) are common in East Asia. To investigate the genomic difference of HBV genotype C between two separated regions, 50 subgenotype Cs-infected Vietnamese and 70 subgenotype Ce-infected Japanese patients were enrolled for analysis. The patients were categorized to either a hepatocellular carcinoma group (HCC) or a non-HCC group including liver cirrhosis, chronic hepatitis, and asymptomatic carriers. HBV serology, HBV-DNA level, and variations in core promoter/pre-core region were examined. Phylogenetic analysis based on the full genome sequences and nucleotide sequences partly in the S gene and in the P gene revealed that all Japanese strains (70/70) were subgenotype Ce, and nearly all of the Vietnamese strains (50/51) were subgenotype Cs, excluding one subgenotype C5. C1858 and G1775 were common in the Vietnamese (64% and 40%) but not in the Japanese (0%). The prevalence of C/A1753 in Vietnamese was higher than that in the Japanese (32% vs. 17.1%), however the frequency of A1896 in the Japanese was significantly higher (32.9% vs. 12%, P < 0.05). Most of the Vietnamese patients with HCC had a high level of HBV-DNA, the Japanese HCC had a relatively low level. In the Vietnamese, C/A1753 and C1858 were associated closely with T1762A1764, higher HBV-DNA levels and higher HCC incidence. The multivariate analysis revealed that male, T1653 and C/A1753 were independent risk factors for HCC. The subgenotypes and unique mutations of HBV genotype C in the Vietnamese and Japanese differed, and C/A1753 and C1858 variants might play a role in the pathogenesis of liver disease in Vietnamese patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607788     DOI: 10.1002/jmv.20934

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Description of a new hepatitis B virus C6 subgenotype found in the Papua province of Indonesia and suggested renaming of a tentative C6 subgenotype found in the Philippines as subgenotype C7.

Authors:  Lolita Cavinta; Guangwen Cao; Stephan Schaefer
Journal:  J Clin Microbiol       Date:  2009-09       Impact factor: 5.948

2.  Hepatitis B virus subgenotypes and basal core promoter mutations in Indonesia.

Authors:  Andi Utama; Sigit Purwantomo; Marlinang Diarta Siburian; Rama Dhenni; Rino Alvani Gani; Irsan Hasan; Andri Sanityoso; Upik Anderiani Miskad; Fardah Akil; Irawan Yusuf; Wenny Astuti Achwan; Soewignjo Soemohardjo; Syafruddin A R Lelosutan; Ruswhandi Martamala; Benyamin Lukito; Unggul Budihusodo; Laurentius Adrianus Lesmana; Ali Sulaiman; Susan Tai
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

3.  Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection.

Authors:  Bui Xuan Truong; Yoshihiko Yano; Vu Tuong VAN; Yasushi Seo; Nguyen Hoai Nam; Nguyen Khanh Trach; Takako Utsumi; Takeshi Azuma; Yoshitake Hayashi
Journal:  Biomed Rep       Date:  2012-08-24

4.  Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis.

Authors:  Yun Liao; Xin Hu; Jie Chen; Bei Cai; Jiangtao Tang; Binwu Ying; Haiqing Wang; Lanlan Wang
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

5.  Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.

Authors:  Masashi Tatsukawa; Akinobu Takaki; Hidenori Shiraha; Kazuko Koike; Yoshiaki Iwasaki; Haruhiko Kobashi; Shin-Ichi Fujioka; Kohsaku Sakaguchi; Kazuhide Yamamoto
Journal:  BMC Cancer       Date:  2011-10-21       Impact factor: 4.430

6.  A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam.

Authors:  Linda Dunford; Michael J Carr; Jonathan Dean; Linh Thuy Nguyen; Thu Hong Ta Thi; Binh Thanh Nguyen; Jeff Connell; Suzie Coughlan; Hien Tran Nguyen; William W Hall; Lan Anh Nguyen Thi
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

7.  Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively.

Authors:  Y M Chen; S H Wu; C N Qiu; D J Yu; X J Wang
Journal:  Braz J Med Biol Res       Date:  2013-07-30       Impact factor: 2.590

8.  Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Shijian Liu; Hongwei Zhang; Chunying Gu; Jianhua Yin; Yongchao He; Jiaxin Xie; Guangwen Cao
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

9.  HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China.

Authors:  Yueming Chen; Daojun Yu; Weiying Zhang; Chunning Qiu; Guoqian Xiang; Weijian Dai; Shenghai Wu; Xianjun Wang
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

10.  Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.

Authors:  Zongguo Yang; Liping Zhuang; Yunfei Lu; Qingnian Xu; Bozong Tang; Xiaorong Chen
Journal:  Oncotarget       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.